AQR Capital Management
DAWN

AQR Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

AQR Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-444,467
Closed -$9.53M – 3915
2026
Q1 		$9.53M Buy
444,467
+12,709
+3% +$179K ﹤0.01% 1363
2025
Q4 		$4.02M Buy
431,758
+323,281
+298% +$2.7M ﹤0.01% 1704
2025
Q3 		$765K Sell
108,477
-171,373
-61% -$1.18M ﹤0.01% 2585
2025
Q2 		$1.82M Sell
279,850
-338,777
-55% -$2.33M ﹤0.01% 1836
2025
Q1 		$4.91M Buy
618,627
+530,429
+601% +$5.71M 0.01% 1132
2024
Q4 		$1.12M Sell
88,198
-42,112
-32% -$586K ﹤0.01% 1830
2024
Q3 		$1.82M Buy
130,310
+17,290
+15% +$247K ﹤0.01% 1553
2024
Q2 		$1.56M Buy
113,020
+94,703
+517% +$1.39M ﹤0.01% 1564
2024
Q1 		$303K Buy
18,317
+8,159
+80% +$122K ﹤0.01% 2130
2023
Q4 		$148K Buy
+10,158
New +$123K ﹤0.01% 2251
2023
Q3 		– Sell
-14,404
Closed -$172K – 2329
2023
Q2 		$172K Buy
14,404
+1,348
+10% +$17.6K ﹤0.01% 2099
2023
Q1 		$175K Buy
13,056
+3,545
+37% +$69.2K ﹤0.01% 2071
2022
Q4 		$205K Buy
+9,511
New +$195K ﹤0.01% 2076

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Capital Management's DAWN Position: Q2 2026 in Review

AQR Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 444,467 shares — an estimated $9.53M sold.

AQR Capital Management first reported a position in DAWN in Q4 2022 and held it in 13 quarters. The position peaked at $9.53M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • AQR Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • AQR Capital Management sold 444,467 Day One Biopharmaceuticals shares in Q2 2026, an estimated $9.53M.
  • AQR Capital Management first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 13 quarters.
  • AQR Capital Management's Day One Biopharmaceuticals position peaked at $9.53M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.